Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

Launched by UNIVERSITY OF LOUISVILLE · Jun 11, 2009

Keywords

ClinConnect Summary

This clinical trial is looking at how different factors, like stress, hormonal changes, illnesses, and missed medications, might influence the symptoms of relapsing-remitting multiple sclerosis (RR-MS). The researchers want to learn more about why some women with RR-MS experience changes in their symptoms and when these changes occur. The study is currently recruiting female participants aged 18 to 62 who have been diagnosed with RR-MS.

If you join the study, you will be asked to share information about your symptoms and any factors that might affect them. It's important to note that certain women are not eligible to participate, including those who have other autoimmune diseases, have undergone menopause, are pregnant or nursing, have had chemotherapy, or are on specific medications. By participating, you could help researchers understand more about RR-MS and how to better manage its symptoms for women like you.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • females
• • diagnosed with relapsing-remitting multiple sclerosis
• Exclusion Criteria:
• • male
• • no diagnosis of relapsing-remitting MS
• • diagnosis of any other autoimmune disease or fibromyalgia
• • peri-, post-, or surgically menopausal
• • pregnant within past year or nursing
• • history of chemotherapy
• • on experimental medications
• • treatment with steroids in the last 30 days